Cowen and Company Increases Cerus Corp. Price Target to $9.00 (CERS)
Investment analysts at Cowen and Company upped their target price on shares of Cerus Corp. (NASDAQ:CERS) from $7.00 to $9.00 in a note issued to investors on Monday, AR Network reports. Cowen and Company’s target price would indicate a potential upside of 32.94% from the stock’s previous close.
Shares of Cerus Corp. (NASDAQ:CERS) traded up 3.83% during mid-day trading on Monday, hitting $6.77. The stock had a trading volume of 875,052 shares. Cerus Corp. has a 52 week low of $2.68 and a 52 week high of $6.00. The stock’s 50-day moving average is $5. and its 200-day moving average is $4.90. The company’s market cap is $472.1 million.
CERS has been the subject of a number of other recent research reports. Analysts at Wedbush raised their price target on shares of Cerus Corp. from $6.00 to $7.50 in a research note to investors on Monday, September 30th. They now have an “outperform” rating on the stock. Analysts at Cantor Fitzgerald raised their price target on shares of Cerus Corp. from $6.00 to $7.00 in a research note to investors on Thursday, August 1st. They now have a “buy” rating on the stock.
Cerus Corporation is a biomedical products company focused on commercializing the INTERCEPT Blood System to enhance blood safety.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.